The design plan should simultaneously consider observation periods, doses, and observation indicators for both tests.
Suggested Reading
What are the key focus areas in the evaluation of acute, subacute, subchronic, and chronic toxicity, and can… How should the evaluation of new items in the endpoint table be considered after the implementation of the new… GB/T 16886.1-2022 includes implantation in the biological evaluation of dressings. How should implantation tests… For subchronic systemic toxicity studied via implantation, what is the basis for determining the implantation… GB/T 16886.11-2021 adds tests for subchronic systemic toxicity evaluation with dual-route exposure. Which… Why is the extraction period typically 24 hours in China for cytotoxicity testing? What factors may affect biocompatibility risk when using biological test data from similar devices for… Under what conditions can the extraction liquid of dressings be accepted after pH adjustment, centrifugation,… Can products made from materials conforming to YY 0341.1 Appendix B be exempted from biological evaluation? Do all medical devices require chemical characterization? How is the endotoxin limit for wound dressing products determined?